Marc Schrader

Marc Schrader is an experienced pharmaceutical executive currently serving as Chief Technology Officer and Head of Technical Development & Operations at Santhera Pharmaceuticals since September 2022. Prior to this, Marc held the position of CMC Expert at Bazell Pharma AG and served as CMC Leader and Scientific Director at Janssen Inc. from January 2019 to December 2021. Marc was a Board Member of the Swiss Society of Industrial Pharmacists from April 2018 to November 2020 and spent over a decade at Actelion, culminating in roles such as Head of Drug Product Operations. Earlier career highlights include leadership positions at Tillotts Pharma AG. Educational credentials include a Certificate of Advanced Studies from the European Center of Pharmaceutical Medicine, a research degree in intestinal absorption mechanisms from the University of Basel, and a Pharmacy degree from the University of Basel.